Literature DB >> 20338516

Probing the pore drug binding site of microtubules with fluorescent taxanes: evidence of two binding poses.

Isabel Barasoain1, Ana M García-Carril, Ruth Matesanz, Giorgio Maccari, Chiara Trigili, Mattia Mori, Jing-Zhe Shi, Wei-Shuo Fang, José M Andreu, Maurizio Botta, J Fernando Díaz.   

Abstract

The pore site in microtubules has been studied with the use of Hexaflutax, a fluorescent probe derived from paclitaxel. The compound is active in cells with similar effects to paclitaxel, indicating that the pore may be a target to microtubule stabilizing agents. While other taxanes bind microtubules in a monophasic way, thus indicating a single type of sites, Hexaflutax association is biphasic. Analysis of the phases indicates that two different binding sites are detected, reflecting two different modes of binding, which could arise from different arrangements of the taxane or fluorescein moieties in the pore. Association of the 4-4-20 antifluorescein monoclonal antibody-Hexaflutax complex to microtubules remains biphasic, thus indicating that the two phases observed arise from two different poses of the taxane moiety. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20338516     DOI: 10.1016/j.chembiol.2010.02.006

Source DB:  PubMed          Journal:  Chem Biol        ISSN: 1074-5521


  10 in total

1.  Cyclostreptin derivatives specifically target cellular tubulin and further map the paclitaxel site.

Authors:  Enrique Calvo; Isabel Barasoain; Ruth Matesanz; Benet Pera; Emilio Camafeita; Oriol Pineda; Ernest Hamel; Christopher D Vanderwal; José Manuel Andreu; Juan A López; José Fernando Díaz
Journal:  Biochemistry       Date:  2011-12-30       Impact factor: 3.162

2.  Modulation of microtubule interprotofilament interactions by modified taxanes.

Authors:  Ruth Matesanz; Javier Rodríguez-Salarichs; Benet Pera; Angeles Canales; José Manuel Andreu; Jesús Jiménez-Barbero; Wim Bras; Aurora Nogales; Wei-Shuo Fang; José Fernando Díaz
Journal:  Biophys J       Date:  2011-12-20       Impact factor: 4.033

3.  Zampanolide, a potent new microtubule-stabilizing agent, covalently reacts with the taxane luminal site in tubulin α,β-heterodimers and microtubules.

Authors:  Jessica J Field; Benet Pera; Enrique Calvo; Angeles Canales; Didier Zurwerra; Chiara Trigili; Javier Rodríguez-Salarichs; Ruth Matesanz; Arun Kanakkanthara; St John Wakefield; A Jonathan Singh; Jesús Jiménez-Barbero; Peter Northcote; John H Miller; Juan Antonio López; Ernest Hamel; Isabel Barasoain; Karl-Heinz Altmann; José Fernando Díaz
Journal:  Chem Biol       Date:  2012-06-22

Review 4.  Drug discovery targeting cell division proteins, microtubules and FtsZ.

Authors:  Iwao Ojima; Kunal Kumar; Divya Awasthi; Jacob G Vineberg
Journal:  Bioorg Med Chem       Date:  2014-03-05       Impact factor: 3.641

Review 5.  Microtubule stabilizing agents as potential treatment for Alzheimer's disease and related neurodegenerative tauopathies.

Authors:  Carlo Ballatore; Kurt R Brunden; Donna M Huryn; John Q Trojanowski; Virginia M-Y Lee; Amos B Smith
Journal:  J Med Chem       Date:  2012-09-28       Impact factor: 7.446

6.  Synthesis of a Fluorescent Analogue of Paclitaxel That Selectively Binds Microtubules and Sensitively Detects Efflux by P-Glycoprotein.

Authors:  Molly M Lee; Zhe Gao; Blake R Peterson
Journal:  Angew Chem Int Ed Engl       Date:  2017-05-09       Impact factor: 15.336

Review 7.  Recent progress with microtubule stabilizers: new compounds, binding modes and cellular activities.

Authors:  Cristina C Rohena; Susan L Mooberry
Journal:  Nat Prod Rep       Date:  2014-03       Impact factor: 13.423

8.  Anticancer mechanism of 7-α-hydroxyfrullanolide on microtubules and computational prediction of its target binding in triple-negative breast cancer cells.

Authors:  Siriphorn Chimplee; Carl Smythe; Varomyalin Tipmanee; Suchada Sukrong; Kanyanatt Kanokwiroon
Journal:  PeerJ       Date:  2022-05-27       Impact factor: 3.061

9.  Taccalonolide binding to tubulin imparts microtubule stability and potent in vivo activity.

Authors:  A L Risinger; J Li; M J Bennett; C C Rohena; J Peng; D C Schriemer; S L Mooberry
Journal:  Cancer Res       Date:  2013-09-18       Impact factor: 12.701

Review 10.  Zampanolide and dactylolide: cytotoxic tubulin-assembly agents and promising anticancer leads.

Authors:  Qiao-Hong Chen; David G I Kingston
Journal:  Nat Prod Rep       Date:  2014-09       Impact factor: 13.423

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.